Formulate Review Verdict and Update Venture DNA
Synthesise all review findings into a formal, binding decision to continue, repeat, pivot, escalate, or defer the business model. Update the venture DNA and governance records with verified commercial data, updated risk logs, and explicit instructions for subsequent tasks. Document the definitive rationale behind the verdict to maintain transparency and accountability across the programme.
Completing this action delivers an unambiguous governance verdict on the commercial readiness of the business model. It prevents premature scaling on flawed logic, ensuring the venture proceeds with verified commercial mechanics or halts to address fundamental gaps.
The founder must publish an official Review Note detailing the final verdict (continue, repeat, pivot, escalate, or defer), backed by data-room assets and updated venture DNA fields. The note must specify precise next tasks, owner allocations, and trigger conditions for future reviews.
Five questions an expert would ask when reviewing your output
Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.
- 1
What objective evidence justifies a 'continue' decision given the remaining gaps in your enterprise willingness-to-pay validation?
- 2
Why is a pivot preferable to a targeted repeat of price testing in your current target vertical?
- 3
How will this decision impact your immediate runway and upcoming milestone commitments to investors?
- 4
Where are the explicit trigger conditions defined that would force an escalation to expert advice during the next execution cycle?
- 5
Which specific venture DNA parameters have been permanently updated as a result of this business model review?